Clinical Trials Logo
  1. Home
  2. Healthy Subjects
  3. NCT03454685
  4. Details
NCT03454685 Clinical Trial

The Role of Microbiota on the Development of Lung Cancer

Healthy Subjects Clinical Trial

Official title:
The Role of Microbiota on the Development of Lung Cancer

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03454685
Other study ID # 745435
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 30, 2018
Est. completion date March 30, 2020

Study information
Verified date May 2019
Source Wuhan Union Hospital, China
Contact dong xiaorong, Dr
Phone 15071116896
Email zrg27@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Relationship between human microbiota and epidemiology of lung cancer

Description:

In this study,We aim to find some kinds of human microbiota , which were associated with development of non-small cell lung cancer.

Recruitment information / eligibility
Status Recruiting
Enrollment 100
Est. completion date March 30, 2020
Est. primary completion date January 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- non-small cell lung cancer patients

Exclusion Criteria:

- long-term workers in the polluted environment, Patients who had used antibiotics within 1 month before sampling,

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• without intervention type
Without intervention,this study is just an observational study.

Locations
Country Name City State
China Union hospital Wuhan Hubei

Sponsors (1)
Lead Sponsor Collaborator
Xiaorong Dong

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Relationship Between Human Microbiota and Epidemiology of Lung Cancer Find some human microbes that are associated with the development of lung cancer, we can detect these human microbiological content as a biomarker of lung cancer. 1 year
See also
  Status Clinical Trial Phase
Completed NCT05483998 - A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants Phase 1
Recruiting NCT02235012 - Cognitive Biases Under Ketamine N/A
Recruiting NCT02417714 - Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Completed NCT04418973 - Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject. N/A
Completed NCT05088343 - Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects Phase 1
Not yet recruiting NCT06248801 - Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets Phase 1
Terminated NCT04068259 - Single Ascending Dose Study of PBI-4547 in Healthy Subjects Phase 1
Completed NCT03279302 - Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects Phase 1
Not yet recruiting NCT06233162 - Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets Phase 1
Recruiting NCT04159844 - Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects N/A
Completed NCT06137911 - Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults. Phase 1
Completed NCT04849286 - Measurement of HTL0016878 in Cerebrospinal Fluid Phase 1
Not yet recruiting NCT06233227 - Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule Phase 1
Completed NCT04096157 - A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants Phase 1
Completed NCT01200368 - Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants Phase 3
Recruiting NCT05805033 - Peri-Implant Soft Tissue Integration in Humans: Influence of Material N/A
Completed NCT04027803 - Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris® Phase 1
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Completed NCT02903095 - Single Ascending Dose Study of TD-1439 in Healthy Subjects Phase 1
Active, not recruiting NCT02341508 - A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers Phase 1